314 related articles for article (PubMed ID: 32227874)
1. Small Molecule Carboxylates Inhibit Metallo-β-lactamases and Resensitize Carbapenem-Resistant Bacteria to Meropenem.
Tehrani KHME; Brüchle NC; Wade N; Mashayekhi V; Pesce D; van Haren MJ; Martin NI
ACS Infect Dis; 2020 Jun; 6(6):1366-1371. PubMed ID: 32227874
[TBL] [Abstract][Full Text] [Related]
2. Sulfamoyl Heteroarylcarboxylic Acids as Promising Metallo-β-Lactamase Inhibitors for Controlling Bacterial Carbapenem Resistance.
Wachino JI; Jin W; Kimura K; Kurosaki H; Sato A; Arakawa Y
mBio; 2020 Mar; 11(2):. PubMed ID: 32184250
[TBL] [Abstract][Full Text] [Related]
3. Hydroxyhexylitaconic acids as potent IMP-type metallo-β-lactamase inhibitors for controlling carbapenem resistance in
Wachino J-i; Jin W; Norizuki C; Kimura K; Tsuji M; Kurosaki H; Arakawa Y
Microbiol Spectr; 2024 Mar; 12(3):e0234423. PubMed ID: 38315122
[TBL] [Abstract][Full Text] [Related]
4. Structural studies of triazole inhibitors with promising inhibitor effects against antibiotic resistance metallo-β-lactamases.
Muhammad Z; Skagseth S; Boomgaren M; Akhter S; Fröhlich C; Ismael A; Christopeit T; Bayer A; Leiros HS
Bioorg Med Chem; 2020 Aug; 28(15):115598. PubMed ID: 32631568
[TBL] [Abstract][Full Text] [Related]
5. Novel Specific Metallo-β-Lactamase Inhibitor ANT2681 Restores Meropenem Activity to Clinically Effective Levels against NDM-Positive
Zalacain M; Lozano C; Llanos A; Sprynski N; Valmont T; De Piano C; Davies D; Leiris S; Sable C; Ledoux A; Morrissey I; Lemonnier M; Everett M
Antimicrob Agents Chemother; 2021 May; 65(6):. PubMed ID: 33820763
[TBL] [Abstract][Full Text] [Related]
6. H
Chen F; Bai M; Liu W; Kong H; Zhang T; Yao H; Zhang E; Du J; Qin S
Eur J Med Chem; 2021 Nov; 224():113702. PubMed ID: 34303873
[TBL] [Abstract][Full Text] [Related]
7. Metallo-β-lactamases inhibitor fisetin attenuates meropenem resistance in NDM-1-producing Escherichia coli.
Guo Y; Yang Y; Xu X; Li L; Zhou Y; Jia G; Wei L; Yu Q; Wang J
Eur J Med Chem; 2022 Mar; 231():114108. PubMed ID: 35101651
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic Investigations of Metallo-β-lactamase Inhibitors: Strong Zinc Binding Is Not Required for Potent Enzyme Inhibition*.
Wade N; Tehrani KHME; Brüchle NC; van Haren MJ; Mashayekhi V; Martin NI
ChemMedChem; 2021 May; 16(10):1651-1659. PubMed ID: 33534956
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of metal chelators as potential metallo- β -lactamase inhibitors.
Azumah R; Dutta J; Somboro AM; Ramtahal M; Chonco L; Parboosing R; Bester LA; Kruger HG; Naicker T; Essack SY; Govender T
J Appl Microbiol; 2016 Apr; 120(4):860-7. PubMed ID: 26849010
[TBL] [Abstract][Full Text] [Related]
10. Novel metallo-β-lactamases inhibitors restore the susceptibility of carbapenems to New Delhi metallo-lactamase-1 (NDM-1)-harbouring bacteria.
Guo Y; Liu H; Yang M; Ding R; Gao Y; Niu X; Deng X; Wang J; Feng H; Qiu J
Br J Pharmacol; 2024 Jan; 181(1):54-69. PubMed ID: 37539785
[TBL] [Abstract][Full Text] [Related]
11. Fluorinated captopril analogues inhibit metallo-β-lactamases and facilitate structure determination of NDM-1 binding pose.
Kondratieva A; Palica K; Frøhlich C; Hovd RR; Leiros HS; Erdelyi M; Bayer A
Eur J Med Chem; 2024 Feb; 266():116140. PubMed ID: 38242072
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Preclinical Evaluation of TPA-Based Zinc Chelators as Metallo-β-lactamase Inhibitors.
Schnaars C; Kildahl-Andersen G; Prandina A; Popal R; Radix S; Le Borgne M; Gjøen T; Andresen AMS; Heikal A; Økstad OA; Fröhlich C; Samuelsen Ø; Lauksund S; Jordheim LP; Rongved P; Åstrand OAH
ACS Infect Dis; 2018 Sep; 4(9):1407-1422. PubMed ID: 30022668
[TBL] [Abstract][Full Text] [Related]
13. Restoring carbapenem efficacy: a novel carbapenem companion targeting metallo-β-lactamases in carbapenem-resistant Enterobacterales.
Ooi N; Lee VE; Chalam-Judge N; Newman R; Wilkinson AJ; Cooper IR; Orr D; Lee S; Savage VJ
J Antimicrob Chemother; 2021 Jan; 76(2):460-466. PubMed ID: 33152764
[TBL] [Abstract][Full Text] [Related]
14. In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant
Peters BK; Reddy N; Shungube M; Girdhari L; Baijnath S; Mdanda S; Chetty L; Ntombela T; Arumugam T; Bester LA; Singh SD; Chuturgoon A; Arvidsson PI; Maguire GEM; Kruger HG; Naicker T; Govender T
ACS Infect Dis; 2023 Mar; 9(3):486-496. PubMed ID: 36786013
[TBL] [Abstract][Full Text] [Related]
15. Thiol-Containing Metallo-β-Lactamase Inhibitors Resensitize Resistant Gram-Negative Bacteria to Meropenem.
Tehrani KHME; Martin NI
ACS Infect Dis; 2017 Oct; 3(10):711-717. PubMed ID: 28820574
[TBL] [Abstract][Full Text] [Related]
16. Captopril potentiated meropenem activity against MBL-producing carbapenem-resistant Klebsiella pneumoniae: in vitro and in vivo study.
Zhao D; Li H; Yue C; Sun K; Dai Y; Zhang H; Liu Y; Gao Y; Li J
J Inorg Biochem; 2021 May; 218():111381. PubMed ID: 33647540
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a Novel Metallo-β-Lactamase Inhibitor That Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacteriaceae.
Everett M; Sprynski N; Coelho A; Castandet J; Bayet M; Bougnon J; Lozano C; Davies DT; Leiris S; Zalacain M; Morrissey I; Magnet S; Holden K; Warn P; De Luca F; Docquier JD; Lemonnier M
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530861
[TBL] [Abstract][Full Text] [Related]
18. Specific NDM-1 Inhibitor of Isoliquiritin Enhances the Activity of Meropenem against NDM-1-positive
Wang Y; Sun X; Kong F; Xia L; Deng X; Wang D; Wang J
Int J Environ Res Public Health; 2020 Mar; 17(6):. PubMed ID: 32213926
[TBL] [Abstract][Full Text] [Related]
19. Structure-guided optimization of 1H-imidazole-2-carboxylic acid derivatives affording potent VIM-Type metallo-β-lactamase inhibitors.
Yan YH; Li W; Chen W; Li C; Zhu KR; Deng J; Dai QQ; Yang LL; Wang Z; Li GB
Eur J Med Chem; 2022 Jan; 228():113965. PubMed ID: 34763944
[TBL] [Abstract][Full Text] [Related]
20. Methimazole and α-lipoic acid as metallo-β-lactamases inhibitors.
Zhang B; Yang Y; Yuan J; Chen L; Tong H; Huang T; Shi L; Jiang Z
J Antibiot (Tokyo); 2022 May; 75(5):282-286. PubMed ID: 35197545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
